- Home
- SNBR vs LRMR Comparison
SNBR vs LRMR Comparison
Compare SNBR & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNBR
- LRMR
- Stock Information
- Founded
- SNBR 1987
- LRMR N/A
- Country
- SNBR United States
- LRMR United States
- Employees
- SNBR N/A
- LRMR N/A
- Industry
- SNBR Home Furnishings
- LRMR Biotechnology: Pharmaceutical Preparations
- Sector
- SNBR Consumer Discretionary
- LRMR Health Care
- Exchange
- SNBR Nasdaq
- LRMR Nasdaq
- Market Cap
- SNBR 213.8M
- LRMR 204.9M
- IPO Year
- SNBR 1998
- LRMR N/A
- Fundamental
- Price
- SNBR $11.13
- LRMR $4.01
- Analyst Decision
- SNBR Hold
- LRMR Strong Buy
- Analyst Count
- SNBR 2
- LRMR 8
- Target Price
- SNBR $9.00
- LRMR $17.88
- AVG Volume (30 Days)
- SNBR 978.0K
- LRMR 1.8M
- Earning Date
- SNBR 07-30-2025
- LRMR 08-14-2025
- Dividend Yield
- SNBR N/A
- LRMR N/A
- EPS Growth
- SNBR N/A
- LRMR N/A
- EPS
- SNBR N/A
- LRMR N/A
- Revenue
- SNBR $1,524,620,000.00
- LRMR N/A
- Revenue This Year
- SNBR N/A
- LRMR N/A
- Revenue Next Year
- SNBR $4.27
- LRMR N/A
- P/E Ratio
- SNBR N/A
- LRMR N/A
- Revenue Growth
- SNBR N/A
- LRMR N/A
- 52 Week Low
- SNBR $4.48
- LRMR $1.61
- 52 Week High
- SNBR $20.75
- LRMR $9.50
- Technical
- Relative Strength Index (RSI)
- SNBR 68.63
- LRMR 60.80
- Support Level
- SNBR $8.44
- LRMR $3.42
- Resistance Level
- SNBR $11.09
- LRMR $3.97
- Average True Range (ATR)
- SNBR 0.92
- LRMR 0.38
- MACD
- SNBR 0.31
- LRMR 0.02
- Stochastic Oscillator
- SNBR 97.50
- LRMR 67.61
About SNBR Sleep Number Corporation
Sleep Number Corp. is a wellness technology company engaged in the design, manufacturing, marketing and distribution of sleep solutions. The Company generates revenue by marketing and selling its smart beds directly to new and existing customers through its vertically integrated, exclusive, direct-to-consumer retail touch points including Stores, Online, Phone, and Chat (Total Retail). The products offered by the company are Mattresses, Bedding, Pillows and Furniture.
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.